BiotechTube
SSI Diagnostica

SSI Diagnostica

Hillerød, Denmark· Est.
ssid.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

SSI Diagnostica Group is a Denmark-based, global diagnostics company with deep scientific roots dating back over a century. It focuses on infectious diseases, offering a comprehensive portfolio across gastrointestinal, respiratory, and bloodborne pathogens through its integrated brands: SSI Diagnostica, TECHLAB, Beijing Genesee Biotech (BGB), CTK Biotech, and Gulf Coast Scientific. With approximately 600 employees and operations in Denmark, the US, and China, the company serves a vast international market, impacting over 60 million patients annually. Its mission is to be the global leader in making diagnostic expertise accessible everywhere.

Infectious Diseases

Technology Platform

Portfolio of in vitro diagnostic (IVD) technologies including immunoassays, culture media, and molecular diagnostics for infectious diseases, developed under a quality system certified to ISO 13485.

Opportunities

The growing global focus on antimicrobial resistance and pandemic preparedness drives demand for accurate infectious disease diagnostics.
Expansion in high-growth emerging markets, supported by its entities in China and the US, presents a significant opportunity.
The company's expertise in disease surveillance and support for vaccine development aligns with increased public health funding.

Risk Factors

Faces intense competition from large, global diagnostics corporations and nimble specialists.
Evolving regulatory landscapes (e.g., EU IVDR) impose significant compliance costs and complexity.
Rapid technological disruption, particularly from advanced molecular diagnostics, could threaten existing product lines.

Competitive Landscape

SSI Diagnostica competes in the crowded infectious disease diagnostics market against major players like Abbott, Roche, bioMérieux, and Becton Dickinson, as well as many specialized firms. Its competitive edge lies in its deep focus on specific disease areas, a consolidated multi-brand portfolio offering breadth and depth, and a strong global distribution network reaching over 130 countries.

More companies in Diagnostics & Precision Medicine →More companies in Denmark →